1. Home
  2. NKTR vs INVZ Comparison

NKTR vs INVZ Comparison

Compare NKTR & INVZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTR
  • INVZ
  • Stock Information
  • Founded
  • NKTR 1990
  • INVZ 2016
  • Country
  • NKTR United States
  • INVZ Israel
  • Employees
  • NKTR N/A
  • INVZ N/A
  • Industry
  • NKTR Biotechnology: Pharmaceutical Preparations
  • INVZ Auto Parts:O.E.M.
  • Sector
  • NKTR Health Care
  • INVZ Consumer Discretionary
  • Exchange
  • NKTR Nasdaq
  • INVZ Nasdaq
  • Market Cap
  • NKTR 160.4M
  • INVZ 154.6M
  • IPO Year
  • NKTR 1994
  • INVZ N/A
  • Fundamental
  • Price
  • NKTR $0.64
  • INVZ $0.63
  • Analyst Decision
  • NKTR Strong Buy
  • INVZ Strong Buy
  • Analyst Count
  • NKTR 6
  • INVZ 5
  • Target Price
  • NKTR $4.92
  • INVZ $3.24
  • AVG Volume (30 Days)
  • NKTR 2.8M
  • INVZ 2.6M
  • Earning Date
  • NKTR 05-08-2025
  • INVZ 05-07-2025
  • Dividend Yield
  • NKTR N/A
  • INVZ N/A
  • EPS Growth
  • NKTR N/A
  • INVZ N/A
  • EPS
  • NKTR N/A
  • INVZ N/A
  • Revenue
  • NKTR $98,427,000.00
  • INVZ $24,268,000.00
  • Revenue This Year
  • NKTR N/A
  • INVZ $130.12
  • Revenue Next Year
  • NKTR N/A
  • INVZ $135.62
  • P/E Ratio
  • NKTR N/A
  • INVZ N/A
  • Revenue Growth
  • NKTR 9.21
  • INVZ 16.25
  • 52 Week Low
  • NKTR $0.43
  • INVZ $0.45
  • 52 Week High
  • NKTR $1.93
  • INVZ $3.14
  • Technical
  • Relative Strength Index (RSI)
  • NKTR 45.85
  • INVZ 45.83
  • Support Level
  • NKTR $0.43
  • INVZ $0.60
  • Resistance Level
  • NKTR $0.68
  • INVZ $0.65
  • Average True Range (ATR)
  • NKTR 0.08
  • INVZ 0.05
  • MACD
  • NKTR 0.01
  • INVZ 0.02
  • Stochastic Oscillator
  • NKTR 72.41
  • INVZ 83.89

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

About INVZ Innoviz Technologies Ltd. Ordinary shares

Innoviz Technologies Ltd is a provider of solid-state LiDAR and perception solutions that feature technological breakthroughs across core components and bring enhanced vision and superior performance to enable safe autonomous driving at a mass scale. The company provides a complete and comprehensive solution for OEMs and Tier-1 partners that are developing and marketing autonomous driving vehicles to the passenger cars and other relevant markets, such as robotaxis, shuttles, delivery vehicles, buses and trucks, and other industries that require 3-dimensional high resolution sensors. Company's solutions can enable safe autonomy for industries like logistics, drones, robotics, construction and other industrial applications, agriculture, smart city, smart infrastructure, security and mapping.

Share on Social Networks: